Anti-myelin oligodendrocyte glycoprotein antibody-associated disease presenting tumefactive demyelinating lesions and bilateral optic neuritis with chiasmatic lesion

Takamasa Nukui*, Noriyuki Matsuda, Hirofumi Konishi, Tomohiro Hayashi, Mamoru Yamamoto, Ryoko Shibuya, Hiroaki Hirosawa, Ryo Tanaka, Nobuhiro Dougu, Toshiyuki Takahashi, Yuji Nakatsuji

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

A 15-year-old girl presented with a headache accompanied by bilateral visual impairment. Brain magnetic resonance imaging showed tumefactive lesions in the white matter of the right occipital lobe on fluid-attenuated inversion recovery images accompanied by open-ring gadolinium enhancement and high-intensity lesions in the bilateral optic nerve, including chiasma. Since anti-myelin oligodendrocyte glycoprotein (MOG) antibody was detected by blood examination, the patient was diagnosed with anti-MOG antibody-associated disease (MOGAD) exhibiting overlapping characteristics with tumefactive multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSDs). Steroid pulse therapy and plasma exchange therapy completely improved her symptoms, and oral prednisolone therapy prevented relapse of the disease for at least 2 years. Since MOGAD exhibits overlapping characteristics with MS and NMOSD, it is important to screen anti-MOG antibodies in patients with atypical MS and seronegative NMOSD.

Original languageEnglish
Pages (from-to)484-486
Number of pages3
JournalNeurology and Clinical Neuroscience
Volume9
Issue number6
DOIs
StatePublished - 2021/11

Keywords

  • anti-myelin oligodendrocyte glycoprotein antibody
  • bilateral optic neuritis
  • tumefactive lesion

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Anti-myelin oligodendrocyte glycoprotein antibody-associated disease presenting tumefactive demyelinating lesions and bilateral optic neuritis with chiasmatic lesion'. Together they form a unique fingerprint.

Cite this